As part of its advocacy program in Europe, ACRO submits regulatory comments to European officials. This comment letter, submitted by ACRO to EMA in 2020 about The General Data Protection Regulation (GDPR) Secondary Use of Health Data for Medicines and Public Health Purposes (16/07/20) can be found below.